20 LATEST RESOURCES (32 INDEXED)
Cost-Effectiveness Analysis of Physical Activity Interventions for People with Schizophrenia or Bipolar Disorder: Systematic Review · August 2023
Articles
British Journal of Psychiatry
Cost-Utility and Cost-Effectiveness of MoodSwings 2.0, an Internet-Based Self-Management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial · November 2022
Articles
JMIR Mental Health
Healthcare Resource Utilization, Costs and Treatment Patterns in Patients with Bipolar Disorder Treated with Lurasidone or Cariprazine · February 2021
Articles
Journal of Medical Economics
Lurasidone Hydrochloride for Bipolar Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · February 2020
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review · July 2019
Articles (Manuscripts-Versions)
PubMed Central>International Journal of Technology Assessment in Health Care
Atypical Injectable Antipsychotics for Schizophrenia or Bipolar Disorder: A Review of Clinical Effectiveness and Cost-Effectiveness · January 2019
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Cost-Effectiveness of Long-Acting Injectable Aripiprazole Once-Monthly 400 Mg in Bipolar I Disorder in the USA · April 2018
Articles
Journal of Comparative Effectiveness Research
Remote Mood Monitoring for Adults with Bipolar Disorder: An Explorative Study of Compliance and Impact on Mental Health Service Use and Costs · July 2017
Articles
European Psychiatry
Cardiometabolic Comorbidities, Readmission, and Costs in Schizophrenia and Bipolar Disorder: A Real-World Analysis · February 2017
Articles
Annals of General Psychiatry
Cost-Effectiveness of Structured Group Psychoeducation versus Unstructured Group Support for Bipolar Disorder: Results from a Multi-Centre Pragmatic Randomised Controlled Trial · January 2017
Abstracts
Journal of Affective Disorders
Hospital Treatment, Mortality and Healthcare Costs in Relation to Socioeconomic Status among People with Bipolar Affective Disorder · January 2016
Articles
BJPsych Open
Pharmaco-Utilisation and Related Costs of Drugs Used to Treat Schizophrenia and Bipolar Disorder in Italy: The IBIS Study · October 2014
Articles
BMC Psychiatry
Cost-Effectiveness of Asenapine in the Treatment of Patients with Bipolar I Disorder with Mixed Episodes in an Italian Context · July 2014
Articles
Advances in Therapy
Internet-Delivered Psychological Treatments for Mood and Anxiety Disorders: A Systematic Review of Their Efficacy, Safety, and Cost-Effectiveness · May 2014
Articles
PLOS ONE
Formulary Restrictions on Atypical Antipsychotics: Impact on Costs for Patients with Schizophrenia and Bipolar Disorder in Medicaid · February 2014
Articles
American Journal of Managed Care
Cost-Effectiveness of Asenapine in the Treatment of Bipolar Disorder in Canada · January 2014
Articles
BMC Psychiatry
Cost-Effectiveness of Ethyl-Eicosapentaenoic Acid in the Treatment of Bipolar Disorder · April 2013
Articles
NCBI>Therapeutic Advances in Psychopharmacology
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder · February 2013
Articles (Manuscripts-Versions)
PubMed Central>American Journal of Managed Care
Adherence, Persistence of Use, and Costs Associated with Second-Generation Antipsychotics for Bipolar Disorder · September 2011
Articles
Psychiatric Services